STOCK TITAN

Accuray Incorporated (ARAY) 424B Filings

ARAY NASDAQ

Here are the 424B prospectus supplements from Accuray Incorporated (ARAY) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow ARAY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARAY filings page.

Rhea-AI Summary

Accuray Incorporated (ARAY) is registering up to 6,834,308 shares of common stock for resale by existing lenders that hold warrants issued under its senior secured Financing Agreement. The shares consist of 2,990,010 underlying Super Premium Warrants, 2,135,721 underlying Premium Warrants and 1,708,577 underlying Penny Warrants tied to a $18.25 million delayed draw term loan funded on May 19, 2026.

Accuray will not receive proceeds from any resale of these shares, but may receive cash if holders exercise the warrants for cash, which it intends to use for general corporate purposes. The common stock trades on Nasdaq Capital Markets under “ARAY,” and last traded at $0.24 per share on September 10, 2026.

Rhea-AI Summary

Accuray Incorporated filed a prospectus registering 7,000,516 shares of common stock for resale by selling stockholders, representing shares issuable upon exercise of warrants issued under a Loan Amendment. The prospectus states the company will not receive proceeds from resale but will receive proceeds from any cash exercise of the warrants.

The registered shares consist of 3,062,726 Super Premium, 2,187,661 Premium and 1,750,129 Penny warrant-based shares. Shares outstanding were 118,782,630 as of January 30, 2026. Exercise periods run through December 15, 2032 for the Loan Amendment warrants.